Publication Type:

Journal Article

Source:

Annals of dentistry, Volume 49, Number 1, p.36-38, 51 (1990)

URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-0025438660&partnerID=40&md5=89da3ed615ed674e3a973e7b0ba8bb17

Keywords:

adult, aged, article, Blood, Complement 3, Complement 4, complement component C3, complement component C4, complement hemolysis test, Complement Hemolytic Activity Assay, female, human, immunology, leukoplakia, male, Middle Age, mouth disease, Mouth Diseases, Mouth Neoplasms, mouth tumor, Non-U.S. Gov't, Oral, Oral Submucous Fibrosis, precancer, Precancerous Conditions, Support

Abstract:

Total hemolytic complement (CH50) and its fractions (C3 and C4) were estimated in the sera of 50 patients with oral leukoplakia, 50 patients with oral submucous fibrosis and 50 oral cancer patients. The values were compared with that of 50 normal controls. No significant alterations in the values of CH50, C3 or C4 were observed in the sera of patients with either leukoplakia or oral submucous fibrosis whereas the values were found to be altered significantly in oral cancer (P less than 0.001). In the case of oral submucous fibrosis the mean complement levels were slightly lower than those of normal controls and leukoplakia. Age and sex had no influence either on the total complement activity or its fractions (C3 and C4). The serum complement levels may be useful as a biological marker for the early detection of tissue dysplasia.

Notes:

cited By 4

Cite this Research Publication

Dr. Damodaran Vasudevan, Rajendran, R., Remani, P., and Vijayakumar, T., “Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with premalignant and malignant lesions of the oral cavity.”, Annals of dentistry, vol. 49, pp. 36-38, 51, 1990.

207
PROGRAMS
OFFERED
5
AMRITA
CAMPUSES
15
CONSTITUENT
SCHOOLS
A
GRADE BY
NAAC, MHRD
8th
RANK(INDIA):
NIRF 2018
150+
INTERNATIONAL
PARTNERS